Multiple myelomatosis treated with a combination of urethane and an oral nitrogen mustard.
D064987:Cell- and Tissue-Based Therapy; D006801:Humans; D008466:Mechlorethamine; D009101:Multiple Myeloma / Q000628:therapy*; D009281:Naphthalenes / Q000031:analogs & derivatives; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D010949:Plasma; D010950:Plasma Cells; D014520:Urethane / Q000627:therapeutic use*
D009281:Naphthalenes; D009588:Nitrogen Mustard Compounds; C031721:naphthalene; D014520:Urethane; D008466:Mechlorethamine
MYELOMA, PLASMA CELL/therapy; NAPHTHALENE/derivatives; NITROGEN MUSTARDS/therapeutic use; URETHANE/therapeutic use